References
- HirschSRKisslingWBaumlJPowerAO’ConnorRA 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophreniaJ Clin Psychiatry20026351652312088164
- KaneJMCarsonWHSahaAREfficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorderJ Clin Psychiatry20026376377112363115
- VanelliMBursteinPCramerJRefill patterns of atypical and conventional antipsychotic medications at a national retail pharmacy chainPsychiatr Serv2001521248125011533402
- MenzinJBoulangerLFriedmanMMackellJLloydJRTreatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid programPsychiatr Serv20035471972312719504
- KaneJMDrug therapy: schizophreniaN Engl J Med199633434417494570
- AllisonDBMentoreJLHeoMAntipsychotic-induced weight gain: A comprehensive research synthesisAm J Psychiatry19991561686169610553730
- LeuchtSPitschel-WalzGAbrahamDKisslingWEfficacy and extrapyramidal effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomized controlled trialsSchizophr Res19993551689988841
- LeslieDLRosenheckRAUse of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: individual and facility predictorsMed Care20013992393311502950
- American Psychiatric AssociationPractice guideline for the treatment of patients with schizophreniaAm J Psychiatry1997154163
- LehmanAFSteinwachsDMAt issue: Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendationsSchizophr Bull1998241109502542
- Department of Veterans AffairsClinical Guidelines for Management of Persons with PsychosesWashington, D.CVeterans Health Administration1998
- DolderCRLacroJPDunnLBJesteDVAntipsychotic medication adherence: Is there a difference between typical and atypical agentsAm J Psychiatry200215910310811772697
- ValensteinMCopelandLABlowFCPharmacy data identify poorly adherent patients with schizophrenia at increased risk for admissionMed Care20024063063912187177
- DochertyJMahmoudRGroggAKozmaCAntipsychotic maintenance in schizophrenia: partial compliance and clinical outcomeSchizophr Res200360281282
- LehmanAFKreyenbuhlJBuchananRWThe Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003Schizophr Bull20043019321715279040
- LiebermanJAStroupTSMcEvoyJPEffectiveness of antipsychotic drugs in patients with chronic schizophreniaN Engl J Med20053531209122316172203
- RenXSQianSLeeAFHerzLMillerDRKazisLETreatment persistence: A comparison among patients with schizophrenia who were initiated on atypical antipsychotic agentsJ Clin Pharm Ther200631576516476121
- HaynesRBurkeLEImproving patient adherence: state of the art, with a special focus on medication taking for cardiovascular disordersCompliance in Health Care and ResearchNew York, NYFutura Publishing Co2001321
- SclarDAAChinTLSkaerOkamotoMPNakahiroRKGillMAEffect of health education in promoting prescription refill compliance among patients with hypertensionClin Ther1991134894951934001
- SclarDASkaerTLChinAOkamotoMPNakahiroRKGillMAUtility of a transdermal delivery system for antihypertensive therapyPart2Am J Med20019157S60S
- SteinerJFKoepsellTDFihnSDInuiTSA general method of compliance assessment using centralized pharmacy recordsMed Care1988268148233398608
- LamoreauxJThe organizational structure for medical information management in the Department of Veterans Affairs: an overview of major health care databasesMed Care199634MS31448598686
- RenXSQianSKazisLEAn alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia in the Veterans Health AdministrationNeuropsychiatr Dis Treat2007327728419300560
- McCombsJSNicholMBStimmelGLUse patterns for antipsychotic medications in Medicaid patients with schizophreniaJ Clin Psychiatry199960Suppl 1951110507275
- CramerJARosenheckPEnhancing medication compliance for people with serious mental illnessesJ Nerv Ment Disord19991875355
- CitromeLVolavskaJOptimal dosing of atypical anti-psychotics in adults: a review of the current evidenceHarv Rev Psychiatry20021028029112202454
- WeidenPZygmundAThe road back: working with the severely mentally illJournal of Practical Psychiatry and Behavioral Health19973106110
- RenXSLeeAFHuangYHMillerDRQianSKazisLEAdjunctive use of atypical antipsychotics and anticholinergic drugs among patients with schizophreniaJ Clin Pharm Ther2005a30657115659005
- RenXSKazisLELeeAFPatients’ characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophreniaSchizophr Res2005b7716717715894460